BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18929412)

  • 1. High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.
    Green M; Gandhi MK; Camilleri E; Marlton P; Lea R; Griffiths L
    Leuk Res; 2009 May; 33(5):731-4. PubMed ID: 18929412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
    Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
    Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma.
    Impera L; Albano F; Lo Cunsolo C; Funes S; Iuzzolino P; Laveder F; Panagopoulos I; Rocchi M; Storlazzi CT
    Oncogene; 2008 Oct; 27(47):6187-90. PubMed ID: 18622426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental factors may regulate BCL2 associated lymphomagenesis: a very low incidence of BCL2-MBR translocation in Poland.
    Lubiński J; Podolski J; Hadaczek P; Mioduszewska O; Rylski M; Huebner K
    Pol J Pathol; 1995; 46(4):219-24. PubMed ID: 8713288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
    Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
    Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
    Miyamura K; Kobayashi T; Sasaki T; Ibuka T; Imai K; Sakai Y; Kawaguchi K; Miyashita T; Iwaya M; Mizutani S
    Int J Hematol; 1991 Apr; 54(2):137-40. PubMed ID: 1747446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
    Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
    Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of BCL2 translocation in an interphase neucleus using fluorescence in situ hybridization strategy].
    Sun Y; Han X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):472-5. PubMed ID: 11774219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection.
    Libra M; De Re V; Gloghini A; Callari D; Malaponte G; Travali S; Mazzarino MC; Stivala F; Boiocchi M; Carbone A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):165-70. PubMed ID: 15990705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
    Masir N; Campbell LJ; Jones M; Mason DY
    Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
    Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
    Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples.
    Einerson RR; Kurtin PJ; Dayharsh GA; Kimlinger TK; Remstein ED
    Am J Clin Pathol; 2005 Sep; 124(3):421-9. PubMed ID: 16191511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
    Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
    Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
    Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
    Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
    Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.